Bergens Tidende (BT) has published an article featuring Alden Cancer Therapy in relation to their upcoming clinical trial. Every year, 5000 Norwegian men are diagnosed with prostate cancer, and the disease is fatal for 20 percent of them. This fall, Alden Cancer Therapy will start a trial with their cryoimmunotherapy, a method that have fewer side effects and may increase life expectancy as well as increase chance of survival.
We encourage everyone with an exciting research project or innovative idea to participate in the upcoming idea competition! Fill out a short idea description form, and you might be the winner of BTO & Sparebanken Vest’s Idea Competition 2014. The winner receives 300 000 NOK to the development of the project.
The Norwegian Centers of Expertise (NCE) are clusters consisting of companies, universities and research institutions with an important expertise, enabling them to compete worldwide. Two new NCE clusters were announced June 3rd and BTO congratulates the two new entries, NCE Media and NCE Maritime CleanTech.
Hvordan kan et tettere samarbeid mellom helse- og omsorgssektor og næringsliv bidra til bedre helsetjenester? Dette er temaet på konferansen som holdes i Bergen 9. oktober.
The majority of research intensive startups need additional investments and management assistance. BTO established Norsk Innovasjonskapital II AS (NIK II) in cooperation with Televenture to meet this challenge. Likewise, NTNU Technology Transfer and Kjeller Innovation have established respectively, NIK III and NIK I. Now, a fourth NIK fund is about to be established, designed to be open for all the eighth TTOs in Norway.